483 Medimmune Pharma B.V. Jun 2013

483 Medimmune Pharma B.V. Jun 2013

Debra Emerson FDA$119.00 - Available Now

FDA investigators audited the Medimmune Pharma B.V. - Nijmegen, Netherlands facility and issued inspectional observations (via FDA 483) on 21 Jun 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 21 Jun 2013
  • Location: Nijmegen, Netherlands
  • FEI: 3003000472
Add To Cart